An Observational Study to Assess the Utilisation and Safety of Ixekizumab Among Pediatric Patients Treated in the Course of Routine Clinical Care (I1F-MC-B015)

11/06/2021
07/01/2026
EU PAS number:
EUPAS36306
Study
Planned
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

I1F-MC-B015 PASS Protocol v1.0_Redacted

English (4.36 MB - PDF) View document
Study results
Study report
Other information